Inventor · disambiguated record
Ursula Schindler
Also filed as: SCHINDLER URSULA · SCHINDLER URSULA DR
36 granted patents·1 pending application·545 citations·filing 1984–2013
98Inventor score
Files withAVENTIS PHARMA GMBH13CASSELLA FARBWERKE MAINKUR AG12SANOFI AVENTIS DEUTSCHLAND6LICHER THOMAS2SCHINDLER URSULA2
Top patents by PatentIndex Score
37 records- 0189US6897232B2Pyrazole derivatives, their preparation and their use in pharmaceuticalsAVENTIS PHARMA GMBH·Filed 2002·Granted May 24, 2005·33 cites·13 claims
- 0289US6335334B1Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising themAVENTIS PHARMA GMBH·Filed 1999·Granted Jan 1, 2002·61 cites·30 claims
- 0388US4785010A2-(aminoalkyl)-pyrrole derivatives, to treat disorders caused by restriction in cerebral functionCASSELLA FARBWERKE MAINKUR AG·Filed 1985·Granted Nov 15, 1988·27 cites·12 claims
- 0486US7300950B2Pyrazole derivatives, their preparation and their use in pharmaceuticalsSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Nov 27, 2007·8 cites·7 claims
- 0586US6881735B2Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising themAVENTIS PHARMA GMBH·Filed 2001·Granted Apr 19, 2005·19 cites·17 claims
- 0685US6162819APyrazole derivatives, their preparation and their use in pharmaceuticalsAVENTIS PHARMA GMBH·Filed 1998·Granted Dec 19, 2000·59 cites·13 claims
- 0785US4598079A2-(aryl substitued)piperazinones and nootropic compositions based thereonCASSELLA FARBWERKE MAINKUR AG·Filed 1984·Granted Jul 1, 1986·29 cites·14 claims
- 0883US6844361B2Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitorAVENTIS PHARMA GMBH·Filed 2003·Granted Jan 18, 2005·11 cites·1 claims
- 0982US6613772B1Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicamentsAVENTIS PHARMA GMBH·Filed 1998·Granted Sep 2, 2003·52 cites·15 claims
- 1079US7309579B2Method for screening for activators of soluble guanylate cyclase having oxidized heme ironSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Dec 18, 2007·5 cites·15 claims
- 1179US5500436A2-(N-(2-aminomethyl)amino)acetic acid derivatives to inhibit advanced glycosylationCASSELLA FARBWERKE MAINKUR AG·Filed 1994·Granted Mar 19, 1996·49 cites·3 claims
- 1277US8106213B2Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising themSCHINDLER URSULA·Filed 2007·Granted Jan 31, 2012·2 cites·14 claims
- 1377US5679704AUse of 2- (N-(2-aminoethyl)amino) acetic acid derivativesCASSELLA FARBWERKE MAINKUR AG·Filed 1995·Granted Oct 21, 1997·42 cites·3 claims
- 1476US6627628B1Substituted 4-amino-2-aryl-cyclopenta[d]pyrimidines, their production and use and pharmaceutical preparations containing sameAVENTIS PHARMA GMBH·Filed 1999·Granted Sep 30, 2003·35 cites·11 claims
- 1575US8541410B2Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising themSCHINDLER URSULA·Filed 2012·Granted Sep 24, 2013·2 cites·6 claims
- 1674US6913898B2Luminescent method of detecting soluble guanylate cyclaseAVENTIS PHARMA GMBH·Filed 2002·Granted Jul 5, 2005·9 cites·1 claims
- 1773US6500631B1Method for detecting oxidized forms of soluble guanylate cyclaseAVENTIS PHARMA GMBH·Filed 2000·Granted Dec 31, 2002·9 cites·12 claims
- 1873US5043348APyrrolealdehydes, their preparation and their useCASSELLA FARBWERKE MAINKUR AG·Filed 1990·Granted Aug 27, 1991·14 cites·5 claims
- 1971US7045526B2Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising themSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted May 16, 2006·4 cites·21 claims
- 2068US7326789B2Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising themSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Feb 5, 2008·2 cites·10 claims
- 2167US4966901APyrrole derivatives, their preparation and their use as pharmaceutical active compoundsCASSELLA FARBWERKE MAINKUR AG·Filed 1989·Granted Oct 30, 1990·13 cites·4 claims
- 2267US4610984ASubstituted piperazin-1-yl-acetic acid amidesCASSELLA FARBWERKE MAINKUR AG·Filed 1984·Granted Sep 9, 1986·6 cites·9 claims
- 2366US6660746B1Substituted 4-amino-2-aryl-tetrahydoquinazolines, their preparation, their use and pharmaceutical preparations comprising themAVENTIS PHARMA GMBH·Filed 2000·Granted Dec 9, 2003·2 cites·13 claims
- 2465US6548547B1Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activatorsAVENTIS PHARMA GMBH·Filed 1999·Granted Apr 15, 2003·17 cites·6 claims
- 2560US4837225A2,5-dimethylpyrrole derivatives, their preparation and their useCASSELLA FARBWERKE MAINKUR AG·Filed 1986·Granted Jun 6, 1989·9 cites·4 claims
- 2659US8546102B2Methods for determining sodium-proton-exchanger ligand efficiencyLICHER THOMAS·Filed 2009·Granted Oct 1, 2013·1 cites·18 claims
- 2759US8088799B2Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitorLINZ WOLFGANG·Filed 2004·Granted Jan 3, 2012·0 cites·4 claims
- 2858US7351703B2Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activatorsSANOFI AVENTIS DEUTSCHLAND·Filed 2004·Granted Apr 1, 2008·0 cites·3 claims
- 2958US6344468B1Substituted isoindolones and their use as cyclic GMP modulators in medicamentsAVENTIS PHARMA GMBH·Filed 1999·Granted Feb 5, 2002·14 cites·14 claims
- 3054US4898866AThienylpiperazinones, their preparation and their useCASSELLA FARBWERKE MAINKUR AG·Filed 1989·Granted Feb 6, 1990·6 cites·10 claims
- 3153US6809089B2Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activatorsAVENTIS PHARMA GMBH·Filed 2003·Granted Oct 26, 2004·0 cites·9 claims
- 3252US7138398B2Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising themSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Nov 21, 2006·0 cites·18 claims
- 3350US2014106366A1Methods for determining sodium-proton-exchanger ligand efficiencyLICHER THOMAS·Filed 2013·Application pending·0 cites
- 3448US4859663AMultiply substituted pyridine 1-oxide compounds which are useful in treating brain disordersHOECHST AG·Filed 1986·Granted Aug 22, 1989·4 cites·13 claims
- 3538US5192795A2-(aminoalkyl)pyrrolealdehydes, process for their preparation and their useCASSELLA FARBWERKE MAINKUR AG·Filed 1991·Granted Mar 9, 1993·1 cites·16 claims
- 3627US5015659AThienylacetic acid derivatives, process for the preparation thereof, the use thereof, and pharmaceuticals containing these and the preparation thereofCASSELLA FARBWERKE MAINKUR AG·Filed 1990·Granted May 14, 1991·0 cites·6 claims
- 3727US4987134AThienylpiperazines, the use thereof and pharmaceuticals containing theseCASSELLA FARBWERKE MAINKUR AG·Filed 1990·Granted Jan 22, 1991·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Ursula Schindler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →